Cargando…

Reply to: “Clinical characteristics of COVID-19 patients with abnormal liver tests”

Detalles Bibliográficos
Autores principales:	Cai, Qingxian, Chen, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201227/ https://www.ncbi.nlm.nih.gov/pubmed/32387074 http://dx.doi.org/10.1016/j.jhep.2020.04.042

Ejemplares similares

Reply to: “Liver tests abnormalities in COVID-19: trick or treat?”
por: Cai, Qingxian, et al.
Publicado: (2020)

Clinical characteristics of COVID-19 patients with abnormal liver tests
por: Chen, Peng, et al.
Publicado: (2020)

Reply to: Comments on “Association of liver abnormalities with in-hospital mortality in patients with COVID-19”
por: Ding, Ze-yang, et al.
Publicado: (2021)

Characteristics and in-hospital outcomes of COVID-19 patients with abnormal liver biochemical tests
por: Wu, Yanyan, et al.
Publicado: (2021)

Liver tests abnormalities in COVID-19: trick or treat?
por: Vespa, Edoardo, et al.
Publicado: (2020)

Clinical Characteristics of COVID-19 in Patients With Liver Injury
por: Chen, Peng, et al.
Publicado: (2020)

COVID-19: Abnormal liver function tests
por: Cai, Qingxian, et al.
Publicado: (2020)

Reply to: “Association of chronic liver disease with the prognosis of COVID-19 patients”
por: Mallet, Vincent, et al.
Publicado: (2022)

Liver function test abnormalities and their clinical relevance in primary myelofibrosis
por: Barraco, D, et al.
Publicado: (2017)

Reply to “Novaferon, treatment in COVID-19 patients”
por: Zheng, Fang, et al.
Publicado: (2021)

Reply to: “COVID-19-associated liver injury (COVALI): role of hepatologists”
por: Li, Dongxiao, et al.
Publicado: (2021)

Reply to: Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)
por: López-Mendez, Ivan, et al.
Publicado: (2021)

Celiac Disease and Abnormal Liver Function Test
por: Nejad, Mohammad Rostami, et al.
Publicado: (2012)

Characteristics of pregnant patients with COVID-19 and liver injury
por: Deng, Guangtong, et al.
Publicado: (2020)

Reply to: ‘Advances in imaging of brain abnormalities in neuromuscular disease’
por: Finsterer, Josef
Publicado: (2019)

In Reply to “The Spectrum of Renal Abnormalities in Mitochondrial Disorders Is Broad”
por: Imasawa, Toshiyuki, et al.
Publicado: (2022)

Letter regarding “Association of liver abnormalities with in-hospital mortality in patients with COVID-19”
por: Luo, Meng-Si, et al.
Publicado: (2021)

Reply to “The outbreak of COVID-19: An overview”
por: Wu, Yi-Chi, et al.
Publicado: (2020)

In Reply: Hormones and COVID-19
por: Park, Myung S., et al.
Publicado: (2023)

Characteristics of abnormal serum creatine kinase-MB levels in children with COVID-19
por: Wang, Juan-Juan, et al.
Publicado: (2021)

Liver abnormality may develop cerebral vein thrombosis in COVID-19
por: Aghayari Sheikh Neshin, S., et al.
Publicado: (2020)

Reply to “Consensus document on tracheotomy in patients with COVID-19”()
por: Martín Delgado, M.C., et al.
Publicado: (2021)

Reply to: Trajectories of vital signs in patients with Covid-19
por: Redfern, Oliver C., et al.
Publicado: (2021)

Reply to Consensus document on tracheotomy in patients with COVID 19()
por: Pérez Acosta, G., et al.
Publicado: (2021)

Reply to “Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care”
por: Ather, Amber, et al.
Publicado: (2020)

Reply: CPET for Long COVID-19
por: Mancini, Donna M., et al.
Publicado: (2022)

Reply to the syndemic of “COVID-19 and tuberculosis”
por: Patil, Rajashri A., et al.
Publicado: (2023)

In reply—Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research
por: O’Horo, John C., et al.
Publicado: (2021)

Reply to: “Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients”
por: Rodríguez-Perálvarez, Manuel, et al.
Publicado: (2021)

Author reply to letter to the editor “Imaging abnormalities in pediatric neuro-COVID are more diverse than specified”
por: Mun-Ching Wong, Alex, et al.
Publicado: (2023)

Reply: Iron chelation may harm patients with COVID-19
por: Abobaker, Anis
Publicado: (2020)

Reply to: Prognostic implications of vitamin D in patients with COVID-19
por: Hastie, Claire E., et al.
Publicado: (2020)

Reply to the Letter to the Editor “Pathogenesis of pneumoperitoneum in COVID-19 patients”()
por: Gemio del Rey, Ignacio Antonio, et al.
Publicado: (2021)

Plasma hemoglobin in COVID-19: authors’ reply
por: Lancman, Guido, et al.
Publicado: (2020)

In reply—The “Perfect Cytokine Storm” of COVID-19
por: Vijayvargiya, Prakhar, et al.
Publicado: (2020)

Reply To: Response to COVID-19 by the surgical community
por: Chapman, Robert
Publicado: (2020)

Type and dose of heparin in Covid‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)

Reply to Comment on “Osteoporosis in the Age of COVID-19”
por: Girgis, C. M., et al.
Publicado: (2021)

Reply to “Pulmonary toxicity by oxygen and COVID-19”()
por: Belenguer-Muncharaz, A., et al.
Publicado: (2022)

Electrolyte abnormalities in patients hospitalized with COVID-19
por: Malieckal, Deepa A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tc76v2j4d50njo7bchik2m1lg7